Stay updated on Magrolimab Combo in New AML/HR-MDS Clinical Trial
Sign up to get notified when there's something new on the Magrolimab Combo in New AML/HR-MDS Clinical Trial page.

Latest updates to the Magrolimab Combo in New AML/HR-MDS Clinical Trial page
- Check7 days agoNo Change Detected
- Check14 days agoChange DetectedThe ClinicalTrials.gov page footer now displays revision v3.8.0 instead of v3.7.2.SummaryDifference0.1%

- Check21 days agoChange DetectedA site-wide NIH announcement about the transition from “Artificial Intelligence” to “Super Intelligence” appears above the ClinicalTrials.gov study page.SummaryDifference0.8%

- Check28 days agoChange DetectedThe website footer now identifies the site as revision v3.7.2 instead of v3.7.1.SummaryDifference0.1%

- Check35 days agoChange DetectedThe footer now identifies the ClinicalTrials.gov site revision as v3.7.1 instead of v3.7.0.SummaryDifference0.1%

- Check56 days agoChange DetectedA new revision entry (v3.7.0) was added to the study's history, replacing the previous v3.6.6. This indicates the record has been updated to reflect changes in the study record.SummaryDifference0.1%

- Check77 days agoChange DetectedA new revision entry, v3.6.6, has been added to the study record history, while the previous revision, v3.6.5, has been removed. This reflects an administrative update to the ClinicalTrials.gov entry rather than a substantive change to the trial's design, status, or outcomes.SummaryDifference0.1%

Stay in the know with updates to Magrolimab Combo in New AML/HR-MDS Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Magrolimab Combo in New AML/HR-MDS Clinical Trial page.